Market Watch: Nov. 27
Big Picture
Dow Breaks 30,000 Mark on Vaccine Hopes, Cooperation on Biden Transition
U.S. stocks climbed Monday after a third COVID-19 vaccine showed promise in clinical trials, strengthening hopes for an economic rebound in 2021.
While the latest vaccine, from AstraZeneca and Oxford University, initially boosted markets Monday, investor optimism has waned somewhat as serious issues concerning the data emerged later in the week. By Monday’s close, the Dow was up nearly 330 points, while the TSX added 75.


